Filing Details
- Accession Number:
- 0001209191-15-066726
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-08-18 19:58:22
- Reporting Period:
- 2015-08-14
- Filing Date:
- 2015-08-18
- Accepted Time:
- 2015-08-18 19:58:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1394319 | Tracon Pharmaceuticals Inc. | TCON | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1590442 | Partnership Limited Investment V3 Super Jafco | Otemachi First Square, West Tower 11F 1-5-1 Otemachi, Chiyoda-Ku Tokyo M0 100-0004 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-08-14 | 6,574 | $11.71 | 1,787,635 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-08-17 | 3,600 | $11.75 | 1,784,035 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2015-08-18 | 1,000 | $11.53 | 1,783,035 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $11.45 to $11.98. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $11.5875 to $11.96. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $11.40 to $11.65. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
